Liver (Fibrosis)

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Liver (Fibrosis).php on line 2
Liver (Fibrosis)

LE WE PMID CA

Liver (Fibrosis)

1554

Leber (Fibrose)

Aids

alpha2 Macroglobulin

Apolipoprotein AI

Bax

Bilirubin

Collagen3 NTPropeptide

Epithelio mesenchymal transition

GADD153 CHOP

Gamma Glutamyltransferase

Gene transfer

Haptoglobin

Hepatitis B

Hepatitis C

Hyaluronic acid

Liver (Anatomy)

Liver (Elastography)

Liver (Fibrosis)

Liver (Hepatic stellate cell)

Liver (Laboratory medicine)

Portal fibroblasts

Schistosoma

TGF beta

TIMP1

2009 1	Reversibility of liver fibrosis. [20009126] Ann Hepatol 8(4): 283-91 (2009)
2005 2	Diagnosis and treatment of viral liver fibrosis. [19861842] Saudi J Gastroenterol 11(1): 1-19 (2005)
2009 3	Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C. [19519733] Aliment Pharmacol Ther 30(6): 557-76 (2009)
2008 4	Systematic review: hepatic fibrosis - regression with therapy. [18761707] Aliment Pharmacol Ther 28(10): 1175-87 (2008)
2006 5	An appraisal of the histopathological assessment of liver fibrosis. [16531536] Gut 55(4): 569-78 (2006)
1989 6	Non-cirrhotic portal fibrosis. [2651229] Gut 30(3): 406-15 (1989)
2004 7	Portal tract fibrogenesis in the liver. [14688800] Lab Invest 84(2): 153-9 (2004)
2008 8	Non invasive assessment of liver fibrosis. [18566553] Ann Transplant 13(2): 5-11 (2008)
2004 9	An adipocentric view of liver fibrosis and cirrhosis. [15754775] Chang Gung Med J 27(12): 855-68 (2004)
2010 10	Epithelial-mesenchymal transition in the liver. [20615641] Gastroenterol Clin Biol 34(10): 523-8 (2010)
2007 11	Liver fibrosis: from mechanisms to treatment. [18166858] Gastroenterol Clin Biol 31(10): 812-4 (2007)
2008 12	Other non-invasive markers of liver fibrosis. [18973846] Gastroenterol Clin Biol 32(6 Suppl 1): 52-7 (2008)
2008 13	FibroTest-ActiTest as a non-invasive marker of liver fibrosis. [18973844] Gastroenterol Clin Biol 32(6 Suppl 1): 22-39 (2008)
2008 14	Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update. [18973843] Gastroenterol Clin Biol 32(6 Suppl 1): 8-21 (2008)
2008 15	Diagnosis of liver fibrosis in 2008. [18973841] Gastroenterol Clin Biol 32(6 Suppl 1): 1-3 (2008)
2009 16	Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials. [19640664] Gastroenterol Clin Biol 33(10-11): 916-22 (2009)
2009 17	Analogs and fibrosis regression in hepatitis B. [19640665] Gastroenterol Clin Biol 33(10-11): 923-9 (2009)
2011 18	Ultrasound versus biological markers in the evaluation of periportal fibrosis in human Schistosoma mansoni. [22124551] Mem Inst Oswaldo Cruz 106(7): 802-7 (2011)
2006 19	Hepatic stellate cells and alcoholic liver disease. [17092199] Rev Esp Enferm Dig 98(9): 674-84 (2006)
2009 20	Noninvasive assessment of liver fibrosis. Serum markers and transient elastography (FibroScan). [20001156] Rev Esp Enferm Dig 101(11): 787-99 (2009)
2006 21	Kupffer cells and alcoholic liver disease. [16948545] Rev Esp Enferm Dig 98(6): 460-72 (2006)
2009 22	Acoustic radiation force impulse imaging: a new technology for the noninvasive assessment of liver fibrosis? [20076811] J Gastrointestin Liver Dis 18(4): 411-2 (2009)
2007 23	Liver biopsy remains the gold standard for evaluation of chronic hepatitis and fibrosis. [18193125] J Gastrointestin Liver Dis 16(4): 425-6 (2007)
2006 24	Noninvasive biochemical markers of liver fibrosis. [16802010] J Gastrointestin Liver Dis 15(2): 149-59 (2006)
2004 25	Neuroregulation of the neuroendocrine compartment of the liver. [15382010] Anat Rec A Discov Mol Cell Evol Biol 280(1): 910-23 (2004)
2008 26	CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury. [18174271] Am J Physiol Gastrointest Liver Physiol 294(2): G498-505 (2008)
2011 27	A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation. [21299910] Virol J 8(1): 53 (2011)
2008 28	Non-invasive diagnosis of steatosis and fibrosis. [19195629] Diabetes Metab 34(6 Pt 2): 674-9 (2008)
2008 29	Mechanisms of hepatic fibrogenesis. [18471545] Gastroenterology 134(6): 1655-69 (2008)
2008 30	Molecular bases of hepatic fibrogenesis - genetic and therapeutical implications in chronic viral C hepatitis. [18273498] Rom J Morphol Embryol 49(1): 21-5 (2008)
2008 31	Matrix metalloproteinase gene delivery for liver fibrosis. [17577645] Pharm Res 25(2): 249-58 (2008)
2009 32	Molecular pathogenesis of liver fibrosis. [19768189] Trans Am Clin Climatol Assoc 120(-): 361-8 (2009)
2008 33	Assessment of liver fibrosis: noninvasive means. [19568532] Saudi J Gastroenterol 14(4): 163-73 (2008)
2008 34	Serum hyaluronic acid: a promising marker of hepatic fibrosis in chronic hepatitis B. [19568531] Saudi J Gastroenterol 14(4): 161-2 (2008)
2008 35	Cellular sources of extracellular matrix in hepatic fibrosis. [18984465] Clin Liver Dis 12(4): 759-68, viii (2008)
2008 36	Stellate cell contraction: role, regulation, and potential therapeutic target. [18984467] Clin Liver Dis 12(4): 791-803, viii (2008)
2008 37	Immune interactions in hepatic fibrosis. [18984471] Clin Liver Dis 12(4): 861-82, x (2008)
2008 38	Current and future anti-fibrotic therapies for chronic liver disease. [18984475] Clin Liver Dis 12(4): 939-62, xi (2008)
2010 39	Portal fibroblasts: Underappreciated mediators of biliary fibrosis. [20209607] Hepatology 51(4): 1438-44 (2010)
2010 40	Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis. [20828377] BMC Gastroenterol 10(-): 103 (2010)
2011 41	Non-invasive markers for hepatic fibrosis. [21849046] BMC Gastroenterol 11(-): 91 (2011)
2007 42	Meta-analyses of FibroTest diagnostic value in chronic liver disease. [17937811] BMC Gastroenterol 7(-): 40 (2007)
2008 43	Systematic review and meta-analysis of the diagnostic accuracy of fibrosis marker panels in patients with HIV/hepatitis C coinfection. [18215981] HIV Clin Trials 9(1): 43-51 (2008)
2009 44	Hepatic fibrosis. [19396960] Curr Opin Gastroenterol 25(3): 223-9 (2009)
2011 45	Fibrosis in autoimmune and cholestatic liver disease. [21497742] Best Pract Res Clin Gastroenterol 25(2): 245-58 (2011)
2007 46	Gene modulation for treating liver fibrosis. [17725523] Crit Rev Ther Drug Carrier Syst 24(2): 93-146 (2007)
2009 47	Cholangiocyte proliferation and liver fibrosis. [19239726] Expert Rev Mol Med 11(-): e7 (2009)
2007 48	Bioconjugation of oligonucleotides for treating liver fibrosis. [18154454] Oligonucleotides 17(4): 349-404 (2007)
PMC 49	Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury. [23328207] Am J Physiol Gastrointest Liver Physiol 304(6):G605-14 (2013)
PMC 50	Hepatic inflammation and progressive liver fibrosis in chronic liver disease. [24627588] World J Gastroenterol 20(10):2515-32 (2014)
PMC 51	Non-invasive diagnosis of liver fibrosis in chronic hepatitis C. [24659877] World J Gastroenterol 20(11):2854-66 (2014)
PMC 52	Analyzing and modeling rheological behavior of liver fibrosis in rats using shear viscoelastic moduli. [24711358] J Zhejiang Univ Sci B 15(4):375-81 (2014)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Liver (Fibrosis).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Liver (Fibrosis).php on line 92